Related Experiment Videos
Exercise responses during endurance testing at different intensities in patients with COPD
Toru Oga1, Koichi Nishimura, Mitsuhiro Tsukino
1Respiratory Division, Kyoto-Katsura Hospital, 17 Yamadahirao, Nishikyo-ku, Kyoto, Japan. ogat@df7.so-net.ne.jp
Respiratory Medicine
|June 12, 2004
Summary
For chronic obstructive pulmonary disease patients, high-intensity (80%) exercise tests provide more sensitive and reliable endurance time measurements than moderate-intensity (60%) tests. This high-intensity approach is preferable for clinical trials evaluating medical interventions.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
Background:
- Endurance time in submaximal exercise tests is a key outcome in clinical trials for medical interventions.
- The optimal intensity for these tests in patients with chronic obstructive pulmonary disease (COPD) remains underexplored.
Purpose of the Study:
- To compare exercise responses between high-intensity (80% maximum work rate) and moderate-intensity (60% maximum work rate) endurance tests in COPD patients.
- To determine the more appropriate intensity for endurance testing in clinical settings.
Main Methods:
- Thirty-seven COPD patients underwent cycle ergometry endurance tests at 80% and 60% of their maximum work rate.
- Tests were conducted after inhalation of bronchodilators (salbutamol, ipratropium bromide) or placebo.
- Endurance time and its variability were analyzed.
Main Results:
- Endurance time was significantly shorter at the 80% intensity test compared to the 60% intensity test.
- The 80% intensity test exhibited lower coefficients of variation, indicating less variability.
- Statistically significant improvements in endurance time following bronchodilator use were observed only in the 80% intensity test.
Conclusions:
- High-intensity (80%) submaximal exercise testing is more sensitive and less variable for measuring endurance time in COPD patients.
- The 80% intensity test is preferable to the 60% intensity test when endurance time is used as an outcome in clinical trials for COPD interventions.